Mereo BioPharma (MREO) EBT (2023 - 2026)
Mereo BioPharma's (MREO) quarterly EBT came in at -$6.7 million in Q1 2026, up 47.86% year-on-year from -$4.5 million in Q1 2025, and up 8.6% on a QoQ basis from -$7.4 million in Q4 2025.
Mereo BioPharma (MREO) EBT (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of EBT data on file, last reported at -$6.7 million in Q1 2026.
- On a quarterly basis, EBT rose 47.86% year-over-year to -$6.7 million in Q1 2026; TTM through Mar 2026 was -$35.7 million, a 24.33% increase from a year earlier, with the FY2025 full-year figure at -$41.9 million, up 3.18% from the prior year.
- EBT for Q1 2026 stood at -$6.7 million, up from -$7.4 million in the prior quarter.
- Over the last five years, EBT for MREO reached as high as -$1.8 million in Q2 2023 and fell as low as -$15.0 million in Q3 2024.
- Historically, EBT has averaged -$9.4 million across 4 years, with a median of -$9.0 million in 2024.
- Across the five-year window, EBT tumbled 599.89% in 2024 and jumped 53.18% in 2025, its largest moves.
- Year by year, EBT stood at -$9.6 million in 2023, then advanced by 26.92% to -$7.0 million in 2024, then declined by 4.33% to -$7.4 million in 2025, then advanced by 8.6% to -$6.7 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$6.7 million in Q1 2026, -$7.4 million in Q4 2025, and -$7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Mereo BioPharma | 229.80 Mn | 229.80 Mn | - | -6.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.72 Mn |
| Dec 31, 2025 | -7.35 Mn |
| Sep 30, 2025 | -7.02 Mn |
| Jun 30, 2025 | -14.62 Mn |
| Mar 31, 2025 | -12.89 Mn |
| Dec 31, 2024 | -7.05 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | -12.26 Mn |
| Mar 31, 2024 | -8.95 Mn |
| Dec 31, 2023 | -9.64 Mn |
| Sep 30, 2023 | -6.53 Mn |
| Jun 30, 2023 | -1.75 Mn |
| Mar 31, 2023 | -12.08 Mn |